Patents by Inventor Michael Patrick Vincent

Michael Patrick Vincent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12758533
    Abstract: The present invention provides systems for targeted delivery of therapeutic agents to Schlemm's canal (SC) endothelial cells. Also provided are methods for using the systems to treat glaucoma or reduce intraocular pressure.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: October 13, 2026
    Assignee: Northwestern University
    Inventors: Mark Johnson, Amir Vahabikashi, Trevor Stack, Michael Patrick Vincent, Evan Alexander Scott
  • Publication number: 20260256698
    Abstract: Provided herein are rehydratable powdered formulations of nanocarriers that can be used to encompass hydrophobic or hydrophilic cargo. The formulations can be used for medicinal, agricultural, and research applications. Methods of making the formulations are also provided.
    Type: Application
    Filed: November 7, 2025
    Publication date: September 3, 2026
    Inventors: Evan Alexander Scott, Michael Patrick Vincent, Sharan Kumar Reddy Bobbala
  • Publication number: 20260217920
    Abstract: A composite nanoparticle that includes a biodegradable amphiphilic material and a hydrophobic compound having a stable isotope label. The biodegradable amphiphilic material may be a polymeric, non-polymeric, or hybrid polymer/lipid self-assembling system. The composite nanoparticle may be a poly(ethylene glycol)-block-poly(?-caprolactone) (PEG-b-PCL) copolymer, a poly(ethylene glycol)-block-poly(L-lactide) (PEG-b-PLA) copolymer, or poly(ethylene glycol)-block-poly(lactide-co-glycolide) (PEG-b-PLGA) copolymer; and the poly(ethylene glycol) block of any of the polymeric biodegradable amphiphilic copolymers may be poly(ethylene glycol) or methoxy poly(ethylene glycol). The hydrophobic compound of the composite nanoparticle may be a fatty acid, a fatty acid derivative, and a lipid analog having a stable isotope label. Compositions and methods of using and making the composite nanoparticle.
    Type: Application
    Filed: January 22, 2026
    Publication date: July 30, 2026
    Inventor: Michael Patrick Vincent
  • Publication number: 20240307358
    Abstract: The present invention provides systems for targeted delivery of therapeutic agents to Schlemm's canal (SC) endothelial cells. Also provided are methods for using the systems to treat glaucoma or reduce intraocular pressure.
    Type: Application
    Filed: July 11, 2022
    Publication date: September 19, 2024
    Inventors: Mark Johnson, Amir Vahabikashi, Trevor Stack, Michael Patrick Vincent, Evan Alexander Scott
  • Publication number: 20220401367
    Abstract: Provided herein are rehydratable powdered formulations of nanocarriers that can be used to encompass hydrophobic or hydrophilic cargo. The formulations can be used for medicinal, agricultural, and research applications. Methods of making the formulations are also provided.
    Type: Application
    Filed: June 16, 2022
    Publication date: December 22, 2022
    Inventors: Evan Alexander Scott, Michael Patrick Vincent, Sharan Kumar Reddy Bobbala